ciltacabtagen autoleucel

Spain

Drugs containing this active substance

  • CARVYKTI 3.2 × 10E6 - 1 × 10E8 CELLS DISPERSION FOR INFUSION

    It is used to treat adult patients with multiple myeloma, a type of bone marrow cancer, when at least three other treatments have not worked.

    Form: solution for injection

    Active substance Dosage
    ciltacabtagen autoleucel 3.2 X 10⁶ -1.0 X 10⁸ CELULAS

    ATC: L01X L01XL L01XL05

    Manufacturer: Janssen-Cilag International N.V